Gilead is letting go of 34 employees at its Oceanside, California, site.
All entries for: Oncology
January 14, 2026
EMD Serono
Layoffs
Boston, MA
1,001-5,000 employees
EMD Serono, the U.S. division of Merck KGaA, is parting ways with an undisclosed number of employees. The layoffs will affect research staff at the company’s offices in Durham, North Carolina.
Disease Area: Endocrinology, Immune Diseases, Neurological Diseases, Oncology
Drug Type: Small Molecule
January 3, 2026
GSK
Layoffs
San Francisco, CA
50,001+ employees
Up to 350 people across GSK’s U.S. and U.K. workforces could lose their jobs as the pharma reorients its investments with its priorities. The layoffs are expected to affect fewer than 70 individuals in the US, and fewer than 50 in the UK, according to Fierce.
Disease Area: Immune Diseases, Multiple, Oncology, Rare Diseases, Respiratory Diseases
Drug Type: Biologic, Small Molecule
December 12, 2025
Geron Corporation
Layoffs
Foster City, CA
51-200 employees
In a bid to reinvigorate sales of its cancer therapy Rytelo, Geron is reducing its headcount by a third and said it will use the savings to strengthen its commercial strategy and execution for the drug. The company currently has about 260 employees, so the layoffs will affect about 87 people, according to a Thursday news release.
Disease Area: Hematology, Multiple, Oncology
Drug Type: Small Molecule
December 12, 2025
Pfizer
Layoffs
New York, NY
50,001+ employees
Pfizer will part ways with more than 200 employees across Switzerland as part of a continuing effort to slow its cash burn, according to a report from Bloomberg on Dec. 10. After the layoffs, the pharma expects its Switzerland headcount to shrink to around 70 people, down from 300, the publication noted, citing anonymous sources familiar with the matter.
Disease Area: Multiple, Oncology
Drug Type: Biologic, Small Molecule
November 25, 2025
Novartis
Layoffs
Basel, Switzerland
10,001-50,000 employees
Novartis will cut 550 full-time jobs at a facility in Switzerland by the end of 2027. The cuts come as the pharma company is ending production of tablets, capsules, and sterile medicine packaging at a plant in Stein, Switzerland.
Disease Area: Cardiology, Hematology, Immune Diseases, Multiple, Oncology
Drug Type: Biologic, Small Molecule
November 20, 2025
AbbVie
Layoffs
North Chicago, IL
50,001+ employees
AbbVie is laying off 59 employees across three California sites, effective Jan. 9, according to a Worker Adjustment and Retraining Notification (WARN) Act notice filed Nov. 13. AbbVie will permanently close the Dublin and Livermore sites after Jan. 9.
Disease Area: Oncology
Drug Type: Biologic
November 19, 2025
CERO THERAPEUTICS HOLDINGS, INC.
Negative Outlook
South San Francisco, California
1-50 employees
For example, the Medicare Drug Price Negotiation Program, administered by CMS as part of the Inflation Reduction Act of 2022, commonly referred to as the IRA, may apply to our products if they are selected for negotiation, which could materially reduce the amount of revenue we can generate from our products if they are approved.
Disease Area: Oncology
Drug Type: Biologic
November 19, 2025
AbbVie
Discontinued Research
North Chicago, IL
50,001+ employees
AbbVie has decided to call it quits with Google’s Calico Life Sciences. The move will involve layoffs affecting around 100 chemists. AbbVie will use the saved money to fund its biologics and cell and RNA therapies.
Disease Area: Oncology
Drug Type: Biologic